Macular Degeneration

Download PDF

Recent Publications on Macular Degeneration:
Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice. We review the fundamental changes that are now occurring to the management...	19th July, 2008	The Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria,	Clin Exp Optom. 2008 Jul 10;. DOI Direct Link
[OCT-based re-injections for anti-VEGF-treatment for neovascular ARMD.] BACKGROUND: We present an optical coherence tomography (OCT)-based...	19th July, 2008	Universitats-Augenklinik Heidelberg, Im Neuenheimer Feld 400, 69120,	Ophthalmologe. 2008 Jul 19;. DOI Direct Link
Pegaptanib sodium for occult choroidal neovascularization in neovascular age-related macular degeneration: a prospective case series. PurposeTo assess the effects of pegaptanib in the treatment of subfoveal...	19th July, 2008	1Department of Ophthalmology of Creteil, University Paris XII, Creteil,	Eye. 2008 Jul 18;. DOI Direct Link
Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans. PURPOSE: To investigate intraocular concentrations and pharmacokinetics of...	19th July, 2008	Department of Ophthalmology, University of Bonn, Bonn, Germany.	Am J Ophthalmol. 2008 Jul 16;. DOI Direct Link
Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization. Vascular endothelial growth factor (VEGF) is important in pathological...	18th July, 2008	1Department of Molecular Biology, Genzyme Corporation, Framingham, MA,	Gene Ther. 2008 Jul 17;. DOI Direct Link
→View more research publications.

BioNews Results for Macular Degeneration:
Clinical Trial Update	Retinal Physician:  Jul 18 2008 5:00PM Matching: macular degeneration
Protein Transports Nutrients Believed to Protect Against Eye Disease	Newswise:  Jul 17 2008 7:48PM Matching: macular degeneration
Nanoparticle Research in Review of Ophthalmology	Newswise:  Jul 17 2008 11:13AM Matching: macular degeneration
Pipex Sees Strong Data for Dry Age-Related Macular Degeneration Trial	FDA News:  Jul 16 2008 12:41AM Matching: macular degeneration
Nanoparticles: Into the New Frontier	Review of Ophthalmology:  Jul 16 2008 7:19AM Matching: macular degeneration
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Macular Degeneration Clinical Trials:
Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-Related Macular Degeneration	Age-Related Macular Degeneration

Macular Degeneration Patents:
US Patent No.	Title
7381410	Polypeptide compounds for inhibiting angiogenesis and tumor growth
7385606	International font measurement system and method
7387387	Correction of presbyopia using adaptive optics and associated methods
7387779	Anti-angiogenic proteins and fragments and methods of use thereof
7387885	Growth factor homolog zvegf3 polynucleotides
→View more patents.

Companies working in the area of Macular Degeneration from Bioportfolio's Biocorporate database :
Company Name
Active Pass Pharmaceuticals Active Pass' mission is to be the industry leader in the discovery and development of small-molecule drugs that target human ABC transporters. A family of 48 structurally-related molecular pumps, ABC... www.activepass.com/        View full profile
GenVec GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. Each of our gene-based therapeutic product candidates use a common patent... www.genvec.com/        View full profile
Diacrin Incorporated Diacrin is developing transplantable cells for the treatment of human diseases which are characterized by cell dysfunction or cell death and for which current therapies are either inadequate ... www.diacrin.com/        View full profile
→View more Macular Degeneration related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Macular Degeneration scientists - we have details of around 865 individuals working on Macular Degeneration .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.